Investigation of the usefulness of a novel skin-closing device in gastrointestinal surgery: a multicenter randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Malignant or benign diseases of the digestive system requiring an open abdominal wound of 4 cm or greater
- Registration Number
- JPRN-UMIN000048169
- Lead Sponsor
- International University of Health and Welfare.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Exclude cases that fall into any of the following categories (1)Emergency surgery (2)Pregnancy (3)Cases with serious infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time required for skin closure
- Secondary Outcome Measures
Name Time Method Incidence of complications (wound infection, wound dehiscence) within 1 month after surgery, and wound cosmesis 6 months after surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of novel skin-closing devices in abdominal wound healing post-gastrointestinal surgery?
How does the novel skin-closing device compare to traditional suturing techniques in reducing postoperative complications for digestive system malignancies?
Are there specific biomarkers that predict optimal outcomes with the novel skin-closing device in patients with large abdominal incisions?
What are the potential adverse events associated with the novel skin-closing device in gastrointestinal surgical procedures?
What combination therapies or alternative wound closure methods are being evaluated alongside the novel device in this trial?